99-33817. Manufacturer of Controlled Substances Notice of Registration

[Federal Register Volume 64, Number 249 (Wednesday, December 29, 1999)]
[Notices]
[Page 73074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-33817]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated June 8, 1999, and published in the Federal Register 
on July 7, 1999, (64 FR 36718), Roche Diagnostics Corporation, 9115 
Hague Road, Indianapolis, Indiana 46250, made application by letter to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)...........  I
Tetrahydrocannabinols (7370)................  I
Phencyclidine (7471)........................  II
Benzoylecgonine (9180)......................  II
Methadone (9250)............................  II
Morphine....................................  II
------------------------------------------------------------------------

    Roche Diagnostics Corporation plans to manufacture small quantities 
of the above listed controlled substances for incorporation in drug of 
abuse detection kits.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Roche 
Diagnostics Corporation to manufacture the listed controlled substances 
is consistent with the public interest at this time. DEA has 
investigated Roche Diagnostics Corporation to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: December 9, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-33817 Filed 12-28-99; 8:45 am]
BILLING CODE 4410-09-M